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Pancreatic islets are aggregates of endocrine cells required for blood glucose control and diabetes preven-
tion after birth. In this issue of Developmental Cell, Goodyer et al. (2012) reveal a function of calcineurin,
a calcium-activated serine/threonine phosphatase, in postnatal NFATc-regulated expression of genes that
help b cells to form insulin-containing vesicles and enter the cell cycle.Pancreatic islets are endoderm-derived
cell aggregates of variable size (reviewed
by Eberhard and Lammert, 2009). They
are vascularized, innervated, and sur-
rounded by a capsule composed of extra-
cellular matrix (ECM) and glial cells. A
human pancreas contains approximately
one million islets. Pancreatic b cells,
followed by glucagon-secreting a cells,
constitute the majority of endocrine cells
within an islet.
b cells are the only cell type in the
human body able to regulate blood
glucose levels by secreting insulin. These
cells therefore increase their insulin
expression and number of insulin-con-
taining vesicles (or dense core granules,
DCGs), grow in cell size, and proliferate
whenever the body needs more insulin.
This adaptation happens during normal
growth or upon insulin resistance caused
by weight gain, obesity, or pregnancy (re-
viewed by Eberhard and Lammert, 2009).
The most dramatic adaptation of b cells,
however, takes place immediately after
birth, when the newborn gets discon-
nected from the mother’s circulatory
system and needs to regulate blood
glucose levels using its own secreted
insulin. Thus, most mouse lines deficient
for genes strictly required for b cell func-
tion (such as the insulin genes) survive
embryogenesis but die within few days
after birth (Duvillie´ et al., 1997). In this
issue of Developmental Cell, Goodyer
et al. (2012) show that calcineurin/NFATc
signaling is necessary for neonatal b cell
development to ensure blood glucose
control and viability of the newborn. Using
gene-deficient mice, they demonstratean essential role of calcineurin in insulin
expression, formation of DCGs, insulin
secretion, and b cell proliferation, all
functions needed for the viability of
a newborn mammal. Their results also
indicate a role of calcineurin/NFATc
signaling in the proliferation of human
b cells.
b cells take up D-glucose along with
other nutrients from the blood and
aerobically metabolize it, increasing the
intracellular concentration of adenosine-
50-triphosphate (ATP) (Figure 1). ATP-
sensitive potassium channels close,
resulting in the depolarization of the
plasma membrane and the opening of
voltage-dependent calcium channels.
The influx of calcium ions (Ca2+) triggers
the fusion of DCGs with the plasma
membrane. This event releases insulin
(reviewed by Ashcroft and Rorsman,
2012). The blood stream then carries
insulin to various tissues, such as liver,
muscle, and adipose tissue, where it trig-
gers glucose uptake and/or storage of
glucose and other nutrients.
Seung Kim and colleagues have previ-
ously shown that calcineurin in b cells
promotes b cell proliferation and function
(Heit et al., 2006). Goodyer et al. (2012)
show that calcineurin switches on genes
that are key to postnatal maturation and
proliferation of b cells. They further show
that protein substrates of calcineurin,
namely the nuclear factors of activated
T cells, cytoplasmic (NFATc), are involved
in turning on this gene program in b cells,
which is essential for glucose homeo-
stasis and viability of the organism (Good-
yer et al., 2012) (Figure 1).Developmental CPancreatic islets express four NFATc
genes (NFATc1 to NFATc4) (Heit et al.,
2006). Interestingly, only vertebrates
harbor these transcription factors, shown
to be required for several vertebrate-
specific features, including an adaptive
immune response (reviewed by Wu et al.,
2007). After calcium/calcineurin-depen-
dent dephosphorylation of NFATc, the
transcription factors rapidly enter the
nucleus and interact with NFAT nuclear
(NFATn) proteins (such as AP1) to activate
gene transcription (Figure 1). Importantly,
the frequently used immunosuppressive
calcineurin inhibitors cyclosporin A (CsA)
and tacrolimus (FK506) induce diabetes
mellitus in about one-tenth of patients
receiving these drugs to prevent rejection
of a grafted organ (Heisel et al., 2004).
This adverse effect illustrates the impor-
tance of calcineurin signaling for normal
glucose homeostasis. Goodyer et al.
now identify NFATc binding sites in the
promoter regions of many genes involved
in b cell proliferation and maturation. They
further show that tacrolimus inhibits
NFATc1-induced expression of these
genes in insulinoma cells and human
islets (Figure 1), suggesting that calci-
neurin inhibitors induce diabetes, at least
in part, by inhibiting essential aspects of
the gene program of mature b cells.
Based on these data, onemight want to
activate calcineurin/NFATc signaling in
b cells of diabetic patients suffering from
b cell dysfunction and death. However,
transgenic b-cell-specific overexpression
of a constitutively active form of calci-
neurin had the opposite outcome in
mice, namely reduced plasma insulinell 23, July 17, 2012 ª2012 Elsevier Inc. 7
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Figure 1. Role of Calcineurin/NFATc Signaling
in Inducing the Gene Program of Mature
Pancreatic b Cells
A scheme of a pancreatic b cell shows some of the
events that, after glucose uptake, lead to the release
of insulin from dense core granules (DCG). Calcineurin
is a calmodulin-dependent serine/threonine phospha-
tase that consists of two subunits (Cnb1 and CnA),
both of which are required for its function. Calcium
influx activates calcineurin, which dephosphorylates
NFATc proteins so that they enter the nucleus to
interact with NFATn proteins in order to initiate gene
transcription involved in b cell proliferation, maturation,
and DCG formation. CsA and FK506 inhibit calcineurin/
NFAT signaling and can decrease b cell function and
induce diabetic symptoms.
Developmental Cell
Previewslevels, a reduced b cell mass, and
increased blood glucose levels (Ber-
nal-Mizrachi et al., 2010). Therefore,
it appears that calcineurin signaling
must be tightly regulated to ensure
proper b cell function in the living
organism.
From an evolutionary perspective,
it is noteworthy that, in contrast to the
NFATc proteins, calcineurin is con-
served from yeast to humans (reviewed
by Li et al., 2011). Thus, it cannot be
ruled out that calcineurin governs basic
functions of insulin release that are
independent of NFATc proteins and
conserved from the insulin-secreting
neurons of invertebrates to the b cells
of human islets. However, calcineurin
signaling via NFATc seems to be
predominant, because overexpression
of active NFATc1 was shown to rescue
calcineurin-deficient b cells (Heit et al.,
2006). Moreover, mice harboring calci-
neurin-deficient islets develop diabetic
symptoms only 2 to 3 weeks after birth,
and not within the first few days after
birth (Goodyer et al., 2012). The latter
phenotype is seen in mice deficient
for highly conserved genes involved
in insulin production and secretion
(Duvillie´ et al., 1997).
As do most important research
publications, the current study raises
a lot of new questions. For example,
does calcineurin/NFATc signaling
affect the delicate vascular networks of
pancreatic islets, shown to be required
for insulin delivery into the blood stream?
Moreover, do the four NFATc proteins
have similar redundant functions or do
they differentially signal in b cells? And
what are the NFATn proteins required
for calcineurin/NFATc-induced postnatal
gene expression in b cells? Finally, is8 Developmental Cell 23, July 17, 2012 ª201the activation of two signaling pathways,
i.e., calcineurin/NFATc signaling and
a still-to-be-characterized NFATn sig-
naling pathway, necessary for b cells to
grow, divide, and increase insulin expres-
sion in response to an increased demand
for insulin? In other words, does the
immunologists’ ‘‘two-signal hypothesis
for T-cell activation’’ (reviewed by Podojil2 Elsevier Inc.and Miller, 2009) also hold true for
b cells, meaning that calcineurin/
NFATc signaling in the absence of
a second activated signaling pathway
(for example, one that activates NFATn
proteins) induces b cell death and
dysfunction rather than b cell prolifera-
tion and growth? Future studies are
needed to answer these pressing
questions about the underlying signal-
ing mechanism. These might reveal
useful drug targets for the treatment
of type 2 diabetes mellitus (T2DM),
which affects close to 300 million
people worldwide.REFERENCES
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